Mesirow Institutional Investment Management, Inc. Collegium Pharmaceutical, Inc Transaction History

Mesirow Institutional Investment Management, Inc.

  • $1.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023
BUY
$21.06 - $24.0 $1.54 Million - $1.76 Million
73,202 Added 20.17%
436,189 $9.37 Million
Q1 2023

May 01, 2023
BUY
$23.0 - $29.88 $1.67 Million - $2.16 Million
72,453 Added 24.94%
362,987 $8.71 Million
Q4 2022

Feb 06, 2023
SELL
$16.14 - $23.55 $1.45 Million - $2.12 Million
-89,831 Reduced 23.62%
290,534 $6.74 Million
Q3 2022

Nov 08, 2022
BUY
$15.46 - $20.1 $5.88 Million - $7.65 Million
380,365 New
380,365 $6.09 Million

Others Institutions Holding COLL

# of Institutions
249
Shares Held
36.2M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.11B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Mesirow Institutional Investment Management, Inc. Portfolio

Follow Mesirow Institutional Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Institutional Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Institutional Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email